Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Expression of ER,PR and HER2/Neu in Initial and Recurrent Breast Cancer.

NCT07056205 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT07056205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07056205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Expression of ER,PR and HER2/Neu in Initial and Recurrent Breast Cancer.
Lead sponsor
Sohag University
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 1, 2021
Completion date
December 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer